A recent study indicates that people who stop using popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who end conventional lifestyle programs.
Published data in a prominent medical journal points out that while obese individuals frequently drop substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Individuals buying such drugs should be cognizant of the potential of quick weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment weight within about one and a half years.
Weighing Therapies
The analysis, which reviewed dozens of studies involving thousands of patients, contrasted the effects of these new drugs with other pills.
The team point out that people who shed pounds through lifestyle changes alone generally experience a more gradual weight regain—approximately 0.1 kg a month—post-intervention.
Understanding the Rapid Rebound
Experts believe the way of the drugs is key to understanding the amplified weight return.
The injections mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of the hormone concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and may also lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement leads to appetite is no longer kept in check, making overeating a significant risk."
A Lifelong Disease?
Medical guidelines advise the jabs for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, considering the likelihood of relapse, the therapy should be considered ongoing.
This perspective is echoed by drug manufacturers, who note that the results "underscore the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.
User Testimonies
Individuals who have come off the medication report a intense resurgence of hunger.
"I experienced something flipping and you're instantly starving," described an individual.
This challenge is compounded if individuals have not adopted sustainable dietary or behavioural modifications during treatment.
Significant Interest
Figures show that a significant number of adults in the UK have tried weight-loss jabs in the last 12 months, with desire remaining high.
- Use is more common among females compared to men.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are powerful tools for weight loss, they are not a standalone solution and lasting health benefits hinges on combined lifestyle changes.
